Supply Chain/Technology

Latest Issue of OR Manager
June 2018
Home Supply Chain/Technology

FDA: New imaging technology promises stable supply of imaging isotope

Editor's Note The Food & Drug Administration (FDA) Commissioner, Scott Gottlieb, MD, on February 8 announced the role the FDA played in the groundbreaking effort to develop a new imaging technology−the RadioGenix System. The technology, which resulted from a collaboration across the federal government and industry, has the potential to…

Read More

By: Judy Mathias
February 9, 2018
Share

FDA: Class I recall of AirLife Humidification Chamber, Heated Breathing Circuit Kits

Editor's Note The Food and Drug Administration (FDA) on January 31 classified the recall by Vyaire Medical (Mettawa, Illinois) of its AirLife Humidification Chamber and Heated Breathing Circuit Kits as Class I, the most serious. The recall was initiated because of a manufacturing error that may cause parts of the…

Read More

By: Judy Mathias
February 6, 2018
Share

Physicians negatively affected by EHRs

Editor's Note Physicians are more likely to leave the profession or reduce their hours if they are uncomfortable using electronic health records (EHRs), the January 24 Medical Economics reports. Although EHRs have the potential to enhance quality of care and clinical coordination, they also increase risk of physician burnout, reduce…

Read More

By: Judy Mathias
January 25, 2018
Share

FDA: AuroMedics recalls one lot of Levofloxacin

Editor's Note The Food & Drug Administration (FDA) on January 18 announced the recall by AuroMedics (East Windsor, New Jersey) of one lot of Levofloxacin in 5% Dextrose Injection 250 mg/50 mL in a single-use flexible container (NDC 55150-243-46, Lot CLF160003, Expiry date May 2018). The product has been found…

Read More

By: Judy Mathias
January 25, 2018
Share

ECRI Institute releases ‘Top 10 Hospital C-suite Watch List’

Editor's Note The ECRI Institute on January 22 announced the released its annual “Top 10 Hospital C-suite Watch List." Among the new and emerging innovations to watch are: Acuity-adaptable rooms, where hospitals keep a patient in the same room from admission to discharge, regardless of acuity level. Insertable cardiac monitors…

Read More

By: Judy Mathias
January 24, 2018
Share

FDA: Baxter recalls another lot of injectable amiodarone

  Editor's Note The Food & Drug Administration (FDA) on January 23 announced the expansion by Baxter (Deerfield, Illinois) of its recall of Nexterone (amiodarone HCL) 150 mg/100 mL premixed injection to include a second lot (NC 109123). Lot NC 109925 was recalled in November 2017. The recall was initiated…

Read More

By: Judy Mathias
January 24, 2018
Share

Postop wound monitoring app helps detect SSIs

Editor's Note A new smartphone app called “WoundCare” is successfully letting patients send images of their surgical wounds to nurses for monitoring, this study finds. The goal of the app, developed by researchers from the Wisconsin Institute of Surgical Outcomes Research, University of Wisconsin, Madison, is earlier detection of surgical…

Read More

By: Judy Mathias
January 23, 2018
Share

New ECRI Institute resource provides solutions for IV-minibag shortage

Editor's Note The ECRI Institute on January 19 announced the release of a special Health Devices guidance article featuring recommendations and alternative solutions for dealing with the IV-fluid minibag (50-250 mL) shortage that resulted form Hurricane Maria in Puerto Rico. The guidance provides a functional equivalence chart for IV solution…

Read More

By: Judy Mathias
January 23, 2018
Share

Top 10 health technology hazards for 2018 named

Medical technology is intended to improve patient care, but even the best technology—if configured, used, or maintained improperly—can lead to problems. Hospitals must regularly examine their hazard control priorities to target the most pressing risks. ECRI Institute’s annual Top 10 Health Technology Hazards report identifies high-priority sources of danger or…

Read More

By: OR Manager
January 19, 2018
Share

FDA issues Safety Alert for Zoll LifeVest 4000 Wearable Cardioverter Defibrillator

Editor's Note The Food & Drug Administration (FDA) on January 17 issued a Safety Alert for the Zoll LifeVest 4000 Wearable Cardioverter Defibrillator because of concerns that the device may fail to deliver treatment to patients if the device is not replaced soon after displaying “Call for service: Device has…

Read More

By: Judy Mathias
January 17, 2018
Share
Live chat by BoldChat